PER 1.18% 8.4¢ percheron therapeutics limited

spp at 1.8c, page-2

  1. 12,605 Posts.
    lightbulb Created with Sketch. 175
    having funding for PhII is very important

    and as mentioned in this release

    US approval for mipomersen would be a "milestone" as well!

    looks like lots of things are gearing up for 2nd half of this year


    and as long as you hold on to your shares you get the potential benefits

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
-0.001(1.18%)
Mkt cap ! $75.72M
Open High Low Value Volume
8.4¢ 8.4¢ 8.3¢ $3.097K 37.23K

Buyers (Bids)

No. Vol. Price($)
1 29206 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 118557 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.